BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0004|87|6|582-587

ISSN： 0009-9163

Source： CLINICAL GENETICS, Vol.87, Iss.6, 2015-06, pp. : 582-587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRCA1 and BRCA2 mutations and the risk for colorectal cancer

By  

CLINICAL GENETICS, Vol. 87, Iss. 5, 2015-05 ,pp. : 411-418

John Wiley & Sons Inc

Access to resources Recommend Favorite

An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice

By  

HUMAN MUTATION, Vol. 39, Iss. 3, 2018-03 ,pp. : 394-405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early‐onset breast/ovarian cancer from Tunisia

By  

CLINICAL GENETICS, Vol. 87, Iss. 2, 2015-02 ,pp. : 155-160

John Wiley & Sons Inc

Access to resources Recommend Favorite

β-2 microglobulin is unsuitable as an internal reference gene for the analysis of gene expression in human colorectal cancer

By Nihon-Yanagi  

Biomedical Reports, Vol. 1, Iss. 2, 2013-01 ,pp. : 193-196

Spandidos Publications

Access to resources Recommend Favorite

Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis

By Guo Yongchen   Bao Yonghua   Ma Ming   Yang Wancai  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-03 ,pp. : 722-722

MDPI

Access to resources Recommend Favorite